Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Recursion Map News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recursion Map. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recursion Map Today - Breaking & Trending Today
Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
SALT LAKE CITY, July 21, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the
Source: finanznachrichten.de
Recursion to Participate in Upcoming Investor Conferences
/PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its...
Source: prnewswire.com
Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results
/PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business...
Source: prnewswire.com
Recursion to Participate in Upcoming Investor Conference
/PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its...
Source: prnewswire.com